Duration of symptoms and disc configuration in chemonucleolysis

E. J. Sella, Ronald Lindsey, W. E. Allen, W. O. Southwick

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Previous studies have compared the effectiveness of chemonucleolysis with surgery, but currently, no objective criteria have been correlated with the clinical outcome. The authors reviewed 28 cases where the patients had undergone chymopapain injection to determine the significance of disc herniation size, disc space height reduction, and the duration of symptoms on clinical outcome. All patients had a complete history, physical examination, and discogram, and most had pre- and postinjection computerized tomography (CT) or myelogram. Nine of the 28 patients were considered clinical failures. Seven underwent laminectomy and discectomy and were improved markedly. Two patients were advised to have surgery but refused and were considered clinical failures. The causes of failure were unknown in three patients, free fragment in two patients, and diabetic neuropathy in one. Only two patients who did well showed complete resolution of the disc deformity on repeat CT scan. The remainder still had evidence of an avascular deformity that persisted although reduced in size. The failures showed no changes in disc size. The height of the disc space was too variable to be correlated with clinical outcome. Patients who failed had a longer duration of symptoms than the ones who did well (15.1 months for failure vs. 5 months). Therefore, some reduction of disc deformity size, but not necessarily complete reduction, is necessary for a good result, and the enzyme is not as effective in patients with long-standing symptoms.

Original languageEnglish (US)
Pages (from-to)89-92
Number of pages4
JournalSpine
Volume13
Issue number1
StatePublished - 1988
Externally publishedYes

Fingerprint

Intervertebral Disc Chemolysis
Chymopapain
Tomography
Diskectomy
Laminectomy
Diabetic Neuropathies
Physical Examination
History

ASJC Scopus subject areas

  • Physiology
  • Clinical Neurology
  • Orthopedics and Sports Medicine

Cite this

Sella, E. J., Lindsey, R., Allen, W. E., & Southwick, W. O. (1988). Duration of symptoms and disc configuration in chemonucleolysis. Spine, 13(1), 89-92.

Duration of symptoms and disc configuration in chemonucleolysis. / Sella, E. J.; Lindsey, Ronald; Allen, W. E.; Southwick, W. O.

In: Spine, Vol. 13, No. 1, 1988, p. 89-92.

Research output: Contribution to journalArticle

Sella, EJ, Lindsey, R, Allen, WE & Southwick, WO 1988, 'Duration of symptoms and disc configuration in chemonucleolysis', Spine, vol. 13, no. 1, pp. 89-92.
Sella EJ, Lindsey R, Allen WE, Southwick WO. Duration of symptoms and disc configuration in chemonucleolysis. Spine. 1988;13(1):89-92.
Sella, E. J. ; Lindsey, Ronald ; Allen, W. E. ; Southwick, W. O. / Duration of symptoms and disc configuration in chemonucleolysis. In: Spine. 1988 ; Vol. 13, No. 1. pp. 89-92.
@article{83cb699068444b1b9d1bf5194231546b,
title = "Duration of symptoms and disc configuration in chemonucleolysis",
abstract = "Previous studies have compared the effectiveness of chemonucleolysis with surgery, but currently, no objective criteria have been correlated with the clinical outcome. The authors reviewed 28 cases where the patients had undergone chymopapain injection to determine the significance of disc herniation size, disc space height reduction, and the duration of symptoms on clinical outcome. All patients had a complete history, physical examination, and discogram, and most had pre- and postinjection computerized tomography (CT) or myelogram. Nine of the 28 patients were considered clinical failures. Seven underwent laminectomy and discectomy and were improved markedly. Two patients were advised to have surgery but refused and were considered clinical failures. The causes of failure were unknown in three patients, free fragment in two patients, and diabetic neuropathy in one. Only two patients who did well showed complete resolution of the disc deformity on repeat CT scan. The remainder still had evidence of an avascular deformity that persisted although reduced in size. The failures showed no changes in disc size. The height of the disc space was too variable to be correlated with clinical outcome. Patients who failed had a longer duration of symptoms than the ones who did well (15.1 months for failure vs. 5 months). Therefore, some reduction of disc deformity size, but not necessarily complete reduction, is necessary for a good result, and the enzyme is not as effective in patients with long-standing symptoms.",
author = "Sella, {E. J.} and Ronald Lindsey and Allen, {W. E.} and Southwick, {W. O.}",
year = "1988",
language = "English (US)",
volume = "13",
pages = "89--92",
journal = "Spine",
issn = "0362-2436",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Duration of symptoms and disc configuration in chemonucleolysis

AU - Sella, E. J.

AU - Lindsey, Ronald

AU - Allen, W. E.

AU - Southwick, W. O.

PY - 1988

Y1 - 1988

N2 - Previous studies have compared the effectiveness of chemonucleolysis with surgery, but currently, no objective criteria have been correlated with the clinical outcome. The authors reviewed 28 cases where the patients had undergone chymopapain injection to determine the significance of disc herniation size, disc space height reduction, and the duration of symptoms on clinical outcome. All patients had a complete history, physical examination, and discogram, and most had pre- and postinjection computerized tomography (CT) or myelogram. Nine of the 28 patients were considered clinical failures. Seven underwent laminectomy and discectomy and were improved markedly. Two patients were advised to have surgery but refused and were considered clinical failures. The causes of failure were unknown in three patients, free fragment in two patients, and diabetic neuropathy in one. Only two patients who did well showed complete resolution of the disc deformity on repeat CT scan. The remainder still had evidence of an avascular deformity that persisted although reduced in size. The failures showed no changes in disc size. The height of the disc space was too variable to be correlated with clinical outcome. Patients who failed had a longer duration of symptoms than the ones who did well (15.1 months for failure vs. 5 months). Therefore, some reduction of disc deformity size, but not necessarily complete reduction, is necessary for a good result, and the enzyme is not as effective in patients with long-standing symptoms.

AB - Previous studies have compared the effectiveness of chemonucleolysis with surgery, but currently, no objective criteria have been correlated with the clinical outcome. The authors reviewed 28 cases where the patients had undergone chymopapain injection to determine the significance of disc herniation size, disc space height reduction, and the duration of symptoms on clinical outcome. All patients had a complete history, physical examination, and discogram, and most had pre- and postinjection computerized tomography (CT) or myelogram. Nine of the 28 patients were considered clinical failures. Seven underwent laminectomy and discectomy and were improved markedly. Two patients were advised to have surgery but refused and were considered clinical failures. The causes of failure were unknown in three patients, free fragment in two patients, and diabetic neuropathy in one. Only two patients who did well showed complete resolution of the disc deformity on repeat CT scan. The remainder still had evidence of an avascular deformity that persisted although reduced in size. The failures showed no changes in disc size. The height of the disc space was too variable to be correlated with clinical outcome. Patients who failed had a longer duration of symptoms than the ones who did well (15.1 months for failure vs. 5 months). Therefore, some reduction of disc deformity size, but not necessarily complete reduction, is necessary for a good result, and the enzyme is not as effective in patients with long-standing symptoms.

UR - http://www.scopus.com/inward/record.url?scp=0023923307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023923307&partnerID=8YFLogxK

M3 - Article

C2 - 3381145

AN - SCOPUS:0023923307

VL - 13

SP - 89

EP - 92

JO - Spine

JF - Spine

SN - 0362-2436

IS - 1

ER -